Clinical Supply Drug Development Packaging 
Drug Target Review
SEPTEMBER 10, 2024
The current landscape of protein drug development is characterised by accelerated timelines where new drugs are approved in months rather than years. In recent years, the biopharmaceutical industry has identified rapid Toxicology (Tox) material supply as the new critical path to IND readiness.
LifeSciVC
AUGUST 21, 2024
Drug development is a long process, and patients are waiting. Keeping ahead of schedule will help to maintain manufacturing efficiencies, ensure adequate supply and product quality, and meet development timelines. Don’t get me wrong. I know we all haven’t exactly been coasting this summer.
Expert insights. Personalized for you.
64 
Let's personalize your content